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genes for acute lung injury in patients with sepsis
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Abstract
Background: To identify critical genes and biological pathways in acute lung injury (ALI), a comparative analysis of
gene expression profiles of patients with ALI + sepsis compared with patients with sepsis alone were performed
with bioinformatic tools.
Methods: GSE10474 was downloaded from Gene Expression Omnibus, including a collective of 13 whole blood
samples with ALI + sepsis and 21 whole blood samples with sepsis alone. After pre-treatment with robust multichip
averaging (RMA) method, differential analysis was conducted using simpleaffy package based upon t-test and fold
change. Hierarchical clustering was also performed using function hclust from package stats. Beisides, functional
enrichment analysis was conducted using iGepros. Moreover, the gene regulatory network was constructed with
information from Kyoto Encyclopedia of Genes and Genomes (KEGG) and then visualized by Cytoscape.
Results: A total of 128 differentially expressed genes (DEGs) were identified, including 47 up- and 81 down-regulated
genes. The significantly enriched functions included negative regulation of cell proliferation, regulation of response to
stimulus and cellular component morphogenesis. A total of 27 DEGs were significantly enriched in 16 KEGG pathways,
such as protein digestion and absorption, fatty acid metabolism, amoebiasis, etc. Furthermore, the regulatory network
of these 27 DEGs was constructed, which involved several key genes, including protein tyrosine kinase 2 (PTK2), v-src
avian sarcoma (SRC) and Caveolin 2 (CAV2).
Conclusion: PTK2, SRC and CAV2 may be potential markers for diagnosis and treatment of ALI.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
5865162912987143
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Background
Acute lung injury (ALI), also called acute respiratory dis-
tress syndrome (ARDS), is a systemic inflammatory re-
sponse syndrome characterized by refractory hypoxemia
and respiratory distress [1]. It can be caused by all kinds
of pathogenic factors inside and outside the lungs (such
as serious infection, aspiration, sepsis, trauma and
shock), principally sepsis [1-3]. ALI appears the earliest
and is with the highest incidence in patients with sepsis
[4,5]. Although advancements in critical care has im-
proved the survival among patients with ALI, the mor-
tality is still as high as 40% and the rate of survivors
with significant pulmonary impairment is approximately
50% [6].
The major challenge is accurate and early diagnosis of
patients with ALI. The current clinical criteria include
pulmonary edema, hypoxemia and widespread capillary
leakage. However, there’s a discrepancy between clinical
criteria and histological autopsy findings [7]. Intraobser-
ver variability in diagnosis is also unavoidable. Thus, the
difficulties in diagnosis make it necessary to identify bio-
markers for ALI. Many studies have been carried out in
different sample sources like pulmonary edema [8], fluid
blood and urine [9,10]. In addition, gene expression pro-
files analysis has been conducted, microarray technology
enables a global investigation of gene expression and
promotes identification of biomarkers of potential diag-
nostic and prognostic significance [11-13]. Moreover, it
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provides insights on the molecular mechanisms under-
lying the ALI [14,15].
In 2009, Howrylak et al. used a gene expression micro-
array data to develop a gene signature of ARDS/ALI be-
tween patients with ALI + sepsis and patients with sepsis
alone, and obtained an eight-gene expression profile that
can distinguish patients with ALI + sepsis from patients
with sepsis alone accurately [11]. In 2013, Chen et al.
downloaded the expression profile deposited by Howrylak
et al. [11], and identified the differentially expressed genes
(DEGs) between patients with ALI + sepsis and patients
with sepsis alone and obtained 12 DEGs. They also con-
structed protein-protein interaction network (PPI) and
conducted functional enrichment analysis, and obtained
two networks (OCLN and HLA-DQB1), as well as
enriched 7 significant functions in OCLN network and 5
functions in HLA-DQB1 network [16]. Using the same
data by Howrylak et al. [11], we aimed to further screen
the DEGs. Especially, hierarchical clustering of genes and
samples by the expression level of the DEGs was per-
formed. And the potential functions of the DEGs were an-
alyzed by Gene Ontology (GO) and pathway enrichment
analyses. In addition, the interaction relationships between
these DEGs significantly enriched in Kyoto Encyclopedia
of Genes and Genomes (KEGG) pathways were investi-
gated by regulatory network.
Methods
Gene expression data
Expression profile of GSE10474 [11] was downloaded from
Gene Expression Omnibus database (GEO, http://www.
ncbi.nlm.nih.gov/geo/), including 13 whole blood samples
with ALI plus sepsis (ALI+ sepsis) and 21 whole blood
samples with sepsis alone. Patients admitted to the Medical
Intensive Care Unit (MICU) of the University of Pittsburgh
Medical Center for no more than 48 h who received mech-
anical ventilation were regarded suitable for the study. And
appropriate patients were recruited from the MICU be-
tween February 2005 and June 2007. Gene expression was
measured using Affymetrix Human Genome U133A 2.0
Array (Affymetrix Inc., SantaClara, California,USA).
Pre-treatment and differential analysis
Raw data were read with package affy of R [17] in Biocon-
ductor [18]. Background correction, normalization and cal-
culation of expression value were performed using the
robust multichip averaging (RMA) method. Differential ana-
lysis was conducted using package Simpleaffy [19] based
upon t-test and fold change. The adjusted p-value < 0.05 and
|log2fold-change (FC)| > 1 were set as the cut-off criteria.
Clustering analysis
As a widely used data analysis tool, hierarchical clustering
is aimed to build a binary tree of the data that successively
combines similar point groups, and visualization of the
tree offers a useful summary of this data [20]. Hierarchical
clustering of genes and samples by the expression level of
the DEGs was performed using hierarchical cluster func-
tion hclust from base package stats of R [17].
Functional enrichment analysis
To obtain an in-depth analysis of the DEGs from the
functional levels, biological process (BP), cell compo-
nents (CC) and molecular function (MF) functional en-
richment analysis was conducted using iGepros [21]
(http://www.biosino.org/iGepros/index.jsp). P-value < 0.05
was set as the cut-off to screen out significant GO terms
and KEGG pathways. Significant KEGG pathways were vi-
sualized using KEGG Mapper tools [22].
Gene regulatory network construction
A total of 27 DEGs were significantly enriched in 16
KEGG pathways. In addition, regulators of these DEGs
and various regulatory relationships (such as activation,
inhibition, phosphorylation, compound binding, coex-
pression, and protein-protein interaction) were retrieved
from the 16 KEGG pathways. The gene regulatory net-
work was visualized by Cytoscape [23]. Proteins in the
network served as the 'nodes', and each pairwise protein
interaction (referred to as edge) was represented by an
undirected link. The property of the network was ana-
lyzed with the plug-in network analysis.
Results
Differentially expressed genes
According to the criteria (adjusted p-value < 0.05 and
|log2FC| > 1), a total of 128 DEGs were identified in pa-
tients with ALI + sepsis compared with patients with
sepsis alone, including 47 up-regulated genes and 81
down-regulated genes.
Functional enrichment analysis results
Top 10 GO terms (BP, CC and MF) are shown in Table 1.
Negative regulation of cell proliferation, regulation of re-
sponse to stimulus and cellular component morphogen-
esis were included in the list.
A total of 120 KEGG pathways were enriched for the
128 DEGs, including 16 significantly enriched pathways
(Table 2), such as fatty acid metabolism, beta-alanine
metabolism, ErbB signaling pathway, ECM-receptor inter-
action, protein digestion and absorption, bile secretion
and gastric acid secretion.
The regulatory network of the DEGs
A total of 27 DEGs were significantly enriched in 16
KEGG pathways. Regulators of these DEGs and various
regulatory relationships (such as activation, inhibition,
phosphorylation, compound binding, co-expression, and
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protein-protein interaction) were retrieved from the 16
KEGG pathways. The regulatory network was constructed
(Figure 1). Especially, protein tyrosine kinase 2 (PTK2),
v-src avian sarcoma (SRC), and Caveolin 2 (CAV2) may be
hub genes for ALI. Furthermore, in the regulatory network
of the DEGs, SRC had interaction relationships with
PTK2, as well as CAV2 were targeted by SRC.
Discussion
A total of 128 DEGs were identified in sepsis-induced
ALI compared with sepsis, including 47 up-regulated
genes and 81 down-regulated genes. Functional enrich-
ment analysis indicated that several metabolism-related
KEGG pathways were enriched in the DEGs, including
fatty acid metabolism and beta-alanine metabolism. Sev-
eral signaling pathways were also significantly enriched
in the DEGs, such as ECM-receptor interaction and
ErbB signaling pathway. Especially, the regulatory net-
work of the 27 DEGs involved several key genes (such as
PTK2, SRC and CAV2).
PTK2 and SRC both were implicated in cell growth and
they were down-regulated in ALI [24,25]. Since repair of
damaged endothelium is important in recovery from ALI
and increased circulating endothelial progenitor cells are
associated with survival [26], we speculated that modula-
tion of these cell growth-related genes could provide an-
other way to treat the disease. Besides, digestion-related
pathways were also disclosed in the DEGs, such as protein
digestion and absorption, bile secretion and gastric acid
Table 1 Top 10 Gene Ontology (GO) terms enriched in
the differentially expressed genes
Ontology GO_ID P-value Count Term
BP GO:0008285 7.85E-05 12 negative regulation of
cell proliferation
GO:0032502 0.000116652 47 developmental process
GO:0060161 0.000160183 2 positive regulation of
dopamine receptor
signaling pathway
GO:0040011 0.000192818 19 locomotion
GO:0032989 0.000216136 16 cellular component
morphogenesis
GO:0048732 0.000225085 8 gland development
GO:0007267 0.000237497 18 cell-cell signaling
GO:0048583 0.000451816 27 regulation of response
to stimulus
GO:0000904 0.000507026 13 cell morphogenesis
involved in differentiation
GO:0018108 0.000561365 6 peptidyl-tyrosine
phosphorylation
CC GO:0005578 3.27E-05 11 proteinaceous
extracellular matrix
GO:0005576 7.15E-05 30 extracellular region
GO:0005938 0.0007889 6 cell cortex
GO:0005615 0.0011351 14 extracellular space
GO:0044420 0.0013032 6 extracellular matrix part
GO:0016323 0.0020977 7 basolateral plasma
membrane
GO:0005624 0.0052989 13 membrane fraction
GO:0009986 0.005548 8 cell surface
GO:0005901 0.0059176 3 caveola
GO:0033593 0.0069353 1 BRCA2-MAGE-D1
complex
MF GO:0019534 0.0004939 2 toxin transporter activity
GO:0008504 0.0010276 2 monoamine
transmembrane
transporter activity
GO:0042803 0.0019488 10 protein homodimerization
activity
GO:0030165 0.0023021 4 PDZ domain binding
GO:0005515 0.0023215 55 protein binding
GO:0005201 0.0026418 4 extracellular matrix
structural constituent
GO:0008144 0.0027622 4 drug binding
GO:0022804 0.0029877 8 active transmembrane
transporter activity
GO:0015101 0.0037119 2 organic cation
transmembrane
transporter activity
GO:0050750 0.0043105 2 low-density lipoprotein
particle receptor binding
BP, biological process; CC, cellular component; MF, molecular function; Count,
number of differentially expressed genes.
Table 2 Significant Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathways enriched in the differentially
expressed genes
KEGG_ID P-value Count Size Term
K04974 0.0058969 4 81 Protein digestion and absorption
K00071 0.0066462 3 43 Fatty acid metabolism
K05146 0.0149273 4 106 Amoebiasis
K00410 0.0164577 2 22 beta-Alanine metabolism
K04950 0.021009 2 25 Maturity onset diabetes of the young
K05100 0.0248666 3 70 Bacterial invasion of epithelial cells
K04976 0.0258013 3 71 Bile secretion
K04971 0.0287182 3 74 Gastric acid secretion
K05310 0.0296041 2 30 Asthma
K04514 0.0313484 4 133 Cell adhesion molecules (CAMs)
K04510 0.0333551 5 200 Focal adhesion
K00040 0.0333724 2 32
Pentose and glucuronate
interconversions
K04512 0.0408489 3 85 ECM-receptor interaction
K04012 0.0432936 3 87 ErbB signaling pathway
K05330 0.0435527 2 37 Allograft rejection
K05215 0.0458106 3 89 Prostate cancer
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secretion, which might be explained by poor health of pa-
tients with ALI.
As an important family for intracellular signal trans-
duction, Src protein tyrosine kinases (PTKs) are associ-
ated with acute inflammatory responses [27-30]. It’s not
expression level alteration of Src PTK but its activation
may be related to reperfusion-induced lung injury [31].
As inhibitor of SRC activation, PP2 can attenuate alveo-
lar macrophage priming for improved lipopolysaccharide
responsiveness and induce a modest reduction in lung
injury [31-33]. And chemical inhibitors directly or indir-
ectly regulating Src PTKs have been used as potential
drugs for the treatment of lung injury [34]. In the regu-
latory network of the DEGs, SRC had interaction rela-
tionships with PTK2. These declared that SRC might
play a role in ALI by mediating PTK2.
Correspondingly, negative regulation of cell proliferation
was the most significant biological pathways in GO en-
richment analysis. CAV2 is a major component of the
inner surface of caveolae. It is involved in essential cellular
functions, including signal transduction, lipid metabolism,
cellular growth control and apoptosis. Its related family
member CAV1 is reported to be a critical regulator of lung
injury [35]. De Almeida et al. find that genetic ablation of
caveolin-2 sensitizes mice to bleomycin-induced injury
[36]. We speculated that CAV2 might play a role in the
pathogenesis of ALI. In the regulatory network of the
DEGs, CAV2 were targeted by SRC, indicating that CAV2
might also be involved in ALI by mediating SRC.
To further look into the molecular mechanisms under-
lying ALI, a gene regulatory network was constructed
for the DEGs and various regulatory relationships were
Figure 1 The regulatory network of the differentially expressed gene. The protein products of the DEGs are in red. The size of a node
correlates with the number of interactions of the node while the thickness of an edge correlates with the edge betweenness of the edge.
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visualized. PTK2, SRC and CAV2 are hub genes in the
network. As discussed above, these genes are related to
cell proliferation. The gene regulatory network further
demonstrated the close association between cell growth
and ALI.
Conclusion
Overall, we carried out an integrated bioinformatics ana-
lysis of genes which may play a role in ALI. A total of
128 DEGs were identified, including 47 up-regulated
genes and 81 down-regulated genes. Functional enrich-
ment analysis showed that cell proliferation and lipid
metabolism were closely related to ALI. Moreover, rele-
vant genes like PTK2, SRC and CAV2 might be potential
biomarkers for diagnosis and treatment of ALI.
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